○Shoji Nakamura¹, Ryohei Yamashita², Yuu Miyauchi^2,3, Yoshitaka Tanaka², Yuji Ishii² (1. Fac. Pharm. Sci., Kyushu Univ., 2. Grad. Sch. Pharm. Sci., Kyushu Univ., 3. Fac. Pharm. Sci., Sojo Univ.)

○Kohei Matsuo¹, Daisuke Aibara¹, Shigeru Yamano¹ (1. Pharm. Sci., Fukuoka Univ.)

○Kota Kurosaki¹, Shunichi Sasaki¹, Yasunari Matsuzaka¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

○Jorge Carlos Pineda Garcia¹, Ren-shi Li^1,2, Ruri Kikura-Hanajiri³, Yoshitaka Tanaka¹, Yuji Ishii¹ (1. Graduate School of Pharmaceutical Sciences, Kyushu University, 2. China Pharmaceutical University, 3. National Institute of Health Sciences)

○Naohiro Oshima¹, Shinobu Sakai¹, Mihono Takagi¹, Yoshiaki Ikarashi¹ (1. NIHS)

○Akira Aoki¹, Yoko Mori¹, Yoshinori Okamoto¹, Hideto Jinno¹ (1. Fac. Pharm., Meijo Univ.)

Keiichi Taniguchi¹, Daisuke Hayashi², Shouta Ogawa¹, Yuji Miyatake¹, Naomi Yasuda³, Mao Nakayama³, Saotomo Itoh¹, Junichi Maeyama⁴, Naoya Ohara⁵, Saburo Yamamoto², Shigeaki Hida¹, Kikuo Onozaki¹, ○Takemasa Takii^1,3 (1. Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Japan, 2. Japan BCG Laboratory, Japan, 3. Department of Mycobacteriology, the research institute of tuberculosis, Japan anti-tuberculosis association, Japan, 4. Department of Safety Research on Blood and Biological Products, Natinal Institute of Infectious Disease, Japan, 5. Department of Oral Microbiology, Graduated School of Medicin, Dentistry, and Pharmaceutical Sciences, Okayama University, Japan)

○Ryusei Muto¹, Tomokazu Shoji^1,2, Manabu Akazawa¹ (1. Public Health and Epidemiology, Meiji Pharmaceutical University, 2. Department of Pharmacy, University of Yamanashi Hospital)